The PE Ratio as of November 2024 (TTM) for GSK plc (GLAXF) is 22.47

According to GSK plc’s latest financial reports and current stock price. The company's current PE Ratio is 22.47. This represents a change of -146.71% compared to the average of -48.11 of the last 4 quarters.

GSK plc (GLAXF) Historical PE Ratio (quarterly & annually)

How has GLAXF PE Ratio performed in the past?

The mean historical PE Ratio of GSK plc over the last ten years is 23.92. The current 22.47 PE Ratio has changed 9.30% with respect to the historical average. Over the past ten years (40 quarters), GLAXF's PE Ratio was at its highest in in the June 2015 quarter at 109.83. The PE Ratio was at its lowest in in the September 2024 quarter at -263.46.

GSK plc (GLAXF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of GSK plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GSK plc (GLAXF) Average PE Ratio

How has GLAXF PE Ratio performed in the past?

The current PE Ratio of GSK plc (GLAXF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

GSK plc (GLAXF) PE Ratio vs. Peers

How is GLAXF’s PE Ratio compared to its peers?

GSK plc’s PE Ratio is less than Santen Pharmaceutical Co., Ltd. (24.31), greater than Ono Pharmaceutical Co., Ltd. (2.53), less than Grifols, S.A. (36.19), less than Pfizer Inc. (36.93), greater than Sanofi (15.43), greater than Roche Holding AG (13.64), greater than Novartis AG (12.63), less than Amgen Inc. (40.23), less than Gilead Sciences, Inc. (106.39), greater than Roche Holding AG (16.92), less than AstraZeneca PLC (34.28), greater than Roche Holding AG (18.60), greater than Novartis AG (12.13), greater than Bristol-Myers Squibb Company PFD CONV 2 (-251.63), less than Astellas Pharma Inc. (0), less than Bristol-Myers Squibb Company (175.24), greater than AstraZeneca PLC (-15.49), less than null (34.38),

Build a custom stock screener for GSK plc (GLAXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GSK plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GSK plc (GLAXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GSK plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.